Identification of Biomarkers for Sarcoidosis and Tuberculosis of the Lung Using Systematic and Integrated Analysis.
Biomarkers, Tumor
/ genetics
Chromobox Protein Homolog 5
Computational Biology
/ methods
Databases, Genetic
Gene Expression
/ genetics
Gene Expression Profiling
/ methods
Gene Expression Regulation
/ genetics
Gene Expression Regulation, Neoplastic
/ genetics
Gene Ontology
Gene Regulatory Networks
/ genetics
Humans
Lung
/ metabolism
Protein Interaction Mapping
/ methods
Protein Interaction Maps
/ genetics
Sarcoidosis
/ diagnosis
Software
Transcriptome
Tuberculosis
/ diagnosis
Journal
Medical science monitor : international medical journal of experimental and clinical research
ISSN: 1643-3750
Titre abrégé: Med Sci Monit
Pays: United States
ID NLM: 9609063
Informations de publication
Date de publication:
23 Jul 2020
23 Jul 2020
Historique:
entrez:
24
7
2020
pubmed:
24
7
2020
medline:
28
4
2021
Statut:
epublish
Résumé
BACKGROUND Sarcoidosis (SARC) is a multisystem inflammatory disease of unknown etiology and pulmonary tuberculosis (PTB) is caused by Mycobacterium tuberculosis. Both of these diseases affect lungs and lymph nodes and share similar clinical manifestations. However, the underlying mechanisms for the similarities and differences in genetic characteristics of SARC and PTB remain unclear. MATERIAL AND METHODS Three datasets (GSE16538, GSE20050, and GSE19314) were retrieved from the Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) in SARC and PTB were identified using GEO2R online analyzer and Venn diagram software. Functional enrichment analysis was performed using Database for Annotation, Visualization and Integrated Discovery (DAVID) and R packages. Two protein-protein interaction (PPI) networks were constructed using Search Tool for the Retrieval of Interacting Genes database, and module analysis was performed using Cytoscape. Hub genes were identified using area under the receiver operating characteristic curve analysis. RESULTS We identified 228 DEGs, including 56 common SARC-PTB DEGs (enriched in interferon-gamma-mediated signaling, response to gamma radiation, and immune response) and 172 SARC-only DEGs (enriched in immune response, cellular calcium ion homeostasis, and dendritic cell chemotaxis). Potential biomarkers for SARC included CBX5, BCL11B, and GPR18. CONCLUSIONS We identified potential biomarkers that can be used as candidates for diagnosis and/or treatment of patients with SARC.
Identifiants
pubmed: 32701935
pii: 925438
doi: 10.12659/MSM.925438
pmc: PMC7397754
doi:
Substances chimiques
Biomarkers, Tumor
0
CBX5 protein, human
0
Chromobox Protein Homolog 5
107283-02-3
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e925438Références
Am J Respir Crit Care Med. 2003 Jun 15;167(12):1695-703
pubmed: 12626344
Semin Respir Infect. 2003 Mar;18(1):23-32
pubmed: 12652451
Eur Respir J. 1997 Jun;10(6):1356-8
pubmed: 9192944
Eur Respir J. 2004 Nov;24(5):811-3
pubmed: 15516677
J Cutan Pathol. 2009 Dec;36(12):1262-8
pubmed: 19469874
Intern Med. 2017;56(15):1957-1960
pubmed: 28768963
J Virol Methods. 1988 Sep;21(1-4):49-59
pubmed: 3053745
Intern Med. 2019 Nov 15;58(22):3299-3304
pubmed: 31327832
Int J Cancer. 2016 Dec 1;139(11):2447-55
pubmed: 27521774
Scand J Infect Dis. 2009;41(10):745-52
pubmed: 19685374
Life Sci. 2018 Nov 1;212:59-69
pubmed: 30236869
Intern Med. 2010;49(18):1997-2001
pubmed: 20847506
Eur Respir J. 2007 Sep;30(3):508-16
pubmed: 17537780
Chest. 2009 Feb;135(2):546-549
pubmed: 19201718
PeerJ. 2019 Jul 10;7:e7313
pubmed: 31333911
Chest. 2013 May;143(5 Suppl):e1S-e29S
pubmed: 23649439
Proc Natl Acad Sci U S A. 2014 Apr 15;111(15):5664-9
pubmed: 24706787
Proc Natl Acad Sci U S A. 2012 May 15;109(20):7853-8
pubmed: 22547807
Expert Rev Proteomics. 2018 Oct;15(10):829-835
pubmed: 30251559
Respir Med. 2019 Jun;152:89-96
pubmed: 31128616
Respir Med Case Rep. 2014 Mar 15;12:4-6
pubmed: 26029525
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818816061
pubmed: 30486755
Thorax. 2006 Dec;61(12):1100
pubmed: 17114376
Am J Cardiol. 2007 Aug 15;100(4):672-6
pubmed: 17697827
Pediatr Cardiol. 2015 Mar;36(3):475-80
pubmed: 25367286
Inflamm Res. 2006 Oct;55(10):441-5
pubmed: 17109071
Indian J Dermatol. 2014 May;59(3):316
pubmed: 24891680
J Proteomics. 2015 Oct 14;128:375-87
pubmed: 26342673
BMC Pulm Med. 2016 Nov 28;16(1):165
pubmed: 27894280
Arch Med Res. 2011 Apr;42(3):199-201
pubmed: 21722815
Arch Virol. 2020 Feb;165(2):321-330
pubmed: 31828511
J Clin Oncol. 2010 Jun 1;28(16):2719-26
pubmed: 20421535
Chest. 2005 Sep;128(3):1830-5
pubmed: 16162793
J Thorac Oncol. 2010 Dec;5(12):2024-36
pubmed: 21155185
Arch Med Sci. 2019 Sep;15(5):1138-1146
pubmed: 31572458
EMBO Mol Med. 2010 Jul;2(7):258-74
pubmed: 20597103
Circ Res. 2005 Mar 4;96(4):401-11
pubmed: 15746448
Am J Physiol Lung Cell Mol Physiol. 2019 Mar 1;316(3):L519-L524
pubmed: 30652492
Int J Cancer. 2014 Jul 15;135(2):319-34
pubmed: 24921089
Am J Respir Crit Care Med. 1999 Oct;160(4):1107-9
pubmed: 10508794